510(k) · Cleared
ClearedCerasorb Dental, Cerasorb M Dental and Cerasorb Perio
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Curasan Ag, Frankfurt Facility · LYC Bone Grafting Material, Synthetic
Cleared on Jul 22, 2005 as substantially equivalent to P800035 (Curasan AG, 1981) and 4 other predicates after a 50-day review. Its family tree reaches back 3 generations to 1995. 18 later devices descend from it.
- Decided
- Jul 22, 2005
- Review
- 50 days
- Class
- Class II
- Product code
- LYC
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 3 generations to K941780 (1995). 17 ancestors in all, the oldest P800035 (1981). 18 later devices descend from it, 17 citing it directly.
- Root · 3 generations backK941780 Orthovita BiogranOrthovita Co. · 1995
- 2 generations backK962494 Perioglas - Bioglass Bone Graft ParticulateUsbiomaterials Corp. · 1996
- 1 generation backK040278 Perioglas-Bioglass Bone Graft SubstituteNovabone Products, LLC · 2004
- This deviceK051443 Cerasorb Dental, Cerasorb M Dental and Cerasorb PerioCurasan Ag, Frankfurt Facility · 2005
- Descendant · cites it directly · 2 of its ownK053374 Ossaplast Dental (Particle Size of 500 to 1000 UM to 2000 UM)Ossacur AG · 2006
- Descendant · cites it directly · 1 of its ownK103709 Ceracell DentalCurasan AG · 2011
- Descendant · cites it directly · 1 of its ownK090950 Bone Plus BCPMegagen Implant Co., Ltd. · 2010
- Descendant · cites it directly · 1 of its ownK083372 Arrowbone-a, Arrowbone-BBrainbase Corporation · 2009
- Descendant · cites it directly · 1 of its ownK081561 Osferion DOlympus Terumo Biomaterials Corporation · 2008
Showing 5 of 18 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 18 · See all- K053374Ossaplast Dental (Particle Size of 500 to 1000 UM to 2000 UM)Ossacur AG · 2006 · cites it directly2descendants
- K103709Ceracell DentalCurasan AG · 2011 · cites it directly1descendant
- K090950Bone Plus BCPMegagen Implant Co., Ltd. · 2010 · cites it directly1descendant
- K083372Arrowbone-a, Arrowbone-BBrainbase Corporation · 2009 · cites it directly1descendant
- K081561Osferion DOlympus Terumo Biomaterials Corporation · 2008 · cites it directly1descendant
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K941780 | Orthovita Biogran | Orthovita Co. | 1995 | — |
| −2 | K962494 | Perioglas - Bioglass Bone Graft Particulate | Usbiomaterials Corp. | 1996 | — |
| −1 | K040278 | Perioglas-Bioglass Bone Graft Substitute | Novabone Products, LLC | 2004 | — |
| 0 (this device) | K051443 | Cerasorb Dental, Cerasorb M Dental and Cerasorb Perio | Curasan Ag, Frankfurt Facility | 2005 | — |
| +1 | K053374 | Ossaplast Dental (Particle Size of 500 to 1000 UM to 2000 UM) | Ossacur AG | 2006 | — |
| +1 | K103709 | Ceracell Dental | Curasan AG | 2011 | — |
| +1 | K090950 | Bone Plus BCP | Megagen Implant Co., Ltd. | 2010 | — |
| +1 | K083372 | Arrowbone-a, Arrowbone-B | Brainbase Corporation | 2009 | — |
| +1 | K081561 | Osferion D | Olympus Terumo Biomaterials Corporation | 2008 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1981 | 1 | 0 |
| 1985 | 1 | 0 |
| 1987 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1995 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2004 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2006 | 1 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2009 | 2 | 0 |
| 2010 | 5 | 0 |
| 2011 | 2 | 0 |
| 2012 | 4 | 0 |
| 2013 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LYC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LYC device
- #1 K253317 Cytrans™ Elashieldscore 14.3 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | P800035 | Peri-OssSummary page 7…ne Repair 9-1 3. PREDICATE DEVICES Cerasorb® DENTAL: PMA800035 PerioGlas®: K992416, K040278 BiO-OSS®, BIO-OSS® BLOCKS, BIO-OSS® Collagen: K033815 BIO-OSS® Anorganic Bovine Bone: K970321 4.… | 1981 |
| * | K992416 | Perioglas- Bioglass Bone Graft ParticulateSummary page 7…9-1 3. PREDICATE DEVICES Cerasorb® DENTAL: PMA800035 PerioGlas®: K992416, K040278 BiO-OSS®, BIO-OSS® BLOCKS, BIO-OSS® Collagen: K033815 BIO-OSS® Anorganic Bovine Bone: K970321 4. INTENDED USE… | 1999 |
| * | K040278 | Perioglas-Bioglass Bone Graft SubstituteSummary page 7…9-1 3. PREDICATE DEVICES Cerasorb® DENTAL: PMA800035 PerioGlas®: K992416, K040278 BiO-OSS®, BIO-OSS® BLOCKS, BIO-OSS® Collagen: K033815 BIO-OSS® Anorganic Bovine Bone: K970321 4. INTENDED USE Cerasorb®… | 2004 |
| * | K033815 | Bio-Oss, Bio-Oss Blocks and Bio-Oss CollagenSummary page 7…9-1 3. PREDICATE DEVICES Cerasorb® DENTAL: PMA800035 PerioGlas®: K992416, K040278 BiO-OSS®, BIO-OSS® BLOCKS, BIO-OSS® Collagen: K033815 BIO-OSS® Anorganic Bovine Bone: K970321 4. INTENDED USE Cerasorb® DENTAL and Cerasorb® M DENTAL are recommended for:… | 2004 |
| * | K970321 | Bio-Oss Anorganic Bovine BoneSummary page 7…PREDICATE DEVICES Cerasorb® DENTAL: PMA800035 PerioGlas®: K992416, K040278 BiO-OSS®, BIO-OSS® BLOCKS, BIO-OSS® Collagen: K033815 BIO-OSS® Anorganic Bovine Bone: K970321 4. INTENDED USE Cerasorb® DENTAL and Cerasorb® M DENTAL are recommended for: Augmentation or reconstructive trea… | 1998 |
What descends from it? (18)
See all 1817 later devices cite it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K053374 | Ossaplast Dental (Particle Size of 500 to 1000 UM to 2000 UM) | 2006 | 2 |
| K103709 | Ceracell Dental | 2011 | 1 |
| K090950 | Bone Plus BCP | 2010 | 1 |
| K083372 | Arrowbone-a, Arrowbone-B | 2009 | 1 |
| K081561 | Osferion D | 2008 | 1 |
| K243745 | FG Bone Graft B | 2025 | 0 |
| K131385 | Easy-Graft | 2013 | 0 |
| K111105 | Curasan Osseolive Dental | 2012 | 0 |
| K113282 | Cerasorb Dental,Ceradorb M Dental, Cerasorb Perio | 2012 | 0 |
| K120152 | Cerasorb Plus | 2012 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 10 years and passes through 4 companies; a new generation was cleared every 1.6 years on median.
- None of the 17 ancestors has a recall.
- Of its descendants, K053374 (Ossacur AG, 2006) has gone furthest, with 2 descendants of its own.
- 1 other device also cites its predicate P800035.
How does its category compare?
All LYC devicesLYC Bone Grafting Material, Synthetic: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LYC
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LYC
267in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LYC
1in 2018
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LYC
2in 2025
MAUDE reports naming product code LYC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 13 | 80 | 0 | 23 |
| 2008 | 8 | 73 | 0 | 25 |
| 2009 | 14 | 100 | 1 | 25 |
| 2010 | 13 | 164 | 2 | 28 |
| 2011 | 9 | 224 | 0 | 21 |
| 2012 | 5 | 120 | 2 | 10 |
| 2013 | 2 | — | 0 | 12 |
| 2014 | 1 | — | 0 | 9 |
| 2015 | 0 | — | 0 | 14 |
| 2016 | 2 | — | 2 | 140 |
| 2017 | 0 | — | 0 | 19 |
| 2018 | 0 | — | 1 | 14 |
| 2019 | 0 | — | 0 | 15 |
| 2020 | 3 | 156 | 0 | 5 |
| 2021 | 0 | — | 0 | 12 |
| 2022 | 2 | — | 0 | 6 |
| 2023 | 0 | — | 0 | 9 |
| 2024 | 0 | — | 0 | 6 |
| 2025 | 3 | 267 | 0 | 2 |
| 2026 | 3 | 266 | 0 | — |
What is it indicated for?
Cerasorb® M DENTAL is recommended for: - Augmentation or reconstructive treatment of the alveolar ridge. - Filling of infrabony periodontal defects. - Filling of defects after root resection, apicoectomy, and cystectomy. - Filling of extraction sockets to enhance preservation of the alveolar ridge. - Elevation of the maxillary sinus floor. - Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and…
Read the full statement (218 words)
Cerasorb® M DENTAL is recommended for:
- Augmentation or reconstructive treatment of the alveolar ridge.
- Filling of infrabony periodontal defects.
- Filling of defects after root resection, apicoectomy, and cystectomy.
- Filling of extraction sockets to enhance preservation of the alveolar ridge.
- Elevation of the maxillary sinus floor.
- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR).
- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR).
Cerasorb® DENTAL is recommended for:
- Augmentation or reconstructive treatment of the alveolar ridge.
- Filling of infrabony periodontal defects.
- Filling of defects after root resection, apicoectomy, and cystectomy.
- Filling of extraction sockets to enhance preservation of the alveolar ridge.
- Elevation of the maxillary sinus floor.
- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR).
- Filling of perio-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR).
Cerasorb® Perio is recommended for:
- Filling and/or reconstruction of non-infected periodontal bone defects in conjunction with other products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR).
- Filling of infrabony periodontal defects
- Filling of single-or multi-wall bone pockets.
- Filling of bifurcations and trifurcations
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K051443 · printed Nov 6, 2026
Cite this page
510(k) Report. “K051443: Cerasorb Dental, Cerasorb M Dental and Cerasorb Perio.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051443
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026